Jack Wilson critiques a recent Danish longitudinal study published in JAMA Psychiatry, which suggests that cannabis use disorder is independently associated with bipolar disorder and unipolar depression.
[read the full story...]Cannabis use and its legalisation: analysing chronic pain in US veterans using electronic health records
In their debut blog, Grace Williamson and Daniel Leightley review a US study on chronic pain, cannabis legalisation, and cannabis use disorder in US veterans.
[read the full story...]Cannabis use in college: genetic predispositions less influential than social environment
Sally Turner reviews a recent study exploring cannabis use in college, which provides useful evidence relating to how universities could promote a sense of community, belonging and support to students who use cannabis.
[read the full story...]Schizophrenia and cannabis use: new evidence measures risk of relapse
In her debut blog, Sally Turner considers a recent study on cannabis use and clinical outcomes in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.
[read the full story...]Young adults do not quit cannabis because of psychosis symptoms, according to new Europe-wide research
Ian Hamilton summarises a recent study exploring whether psychotic-like experiences are related to the discontinuation of cannabis consumption in young adults.
[read the full story...]How to measure cannabis use: introducing the ‘International Cannabis Toolkit’ or iCannToolkit
Ian Hamilton looks at the new International Cannabis Toolkit (iCannToolkit) and considers why it’s so important that we have an internationally agreed and standardised measure for cannabis use.
[read the full story...]Drug use and oral health status
This review investigating the relationship between drug use (methamphetamines, heroin, opiates, cocaine, cannabis and crack) and oral health includes 10 observational studies showing a higher risk of caries.
[read the full story...]The global drug problem: who cares? #LxAddictions19
Ian Hamilton shares his thoughts on the new Drug Use series published yesterday in The Lancet: The global drug problem – change but not progression.
[read the full story...]Can contingency management help people with psychosis give up cannabis? The CIRCLE trial
Ian Hamilton summarises the recently published CIRCLE trial, which looks at the clinical and cost-effectiveness of contingency management for cannabis use in early psychosis.
[read the full story...]We know how to reduce premature deaths from co-morbid mental health and substance use problems, so why aren’t we doing anything about it?
Ian Hamilton looks at a Swedish 42-year follow-up study, which looks at the impact that psychiatric comorbidity can have on premature death in a cohort of patients with substance use disorders.
[read the full story...]